Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 6, 2006, Pages 2424-2427

  Stepan, H ^a   Faber, R ^a   Wessel, N ^b   Wallukat, G ^c   Schultheiss, H P ^d   Walther, T ^d,e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II TYPE 1 RECEPTOR AGONIST AUTOANTIBODY; AUTOANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; OUTCOME ASSESSMENT; PERFUSION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TROPHOBLAST; UTERUS;

ADULT; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33744960698     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2698     Document Type: Article

References (13)

1. Sibai B, Dekker G, Kupferminc M 2005 Pre-eclampsia. Lancet 365:785-799
2. Davison JM, Homuth V, Jeyabalan A, Conrad KP, Karumanchi SA, Quaggin S, Dechend R, Luft FC 2004 New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 9:2440-2448
3. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC 1999 Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103:945-952
4. Xia Y, Wen H, Bobst S, Day M-C, Kellems RE 2003 Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 10:82-93
5. Thway TM, Shlykov SG, Day MC, Sanborn BM, Gilstrap 3rd LC, Xia Y, Kellems RE 2004 Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 110:1612-1619
6. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC 2003 AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107:1632-1639
7. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658
8. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA 2004 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683
9. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss H-P, Faber R, Stepan H 2005 The angiotensin II AT1 receptor autoimmune antibody reflects fundamental alterations of the utero-placental vasculature. Hypertension 46:1-5
10. Stepan H, Geide A, Faber R 2004 Soluble fms-like tyrosine kinase 1. N Engl J Med 351:2241-2242
11. Stepan H, Heihoff-Klose A, Faber R 2004 Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion. Ultrasound Obstet Gynecol 23:579-583
12. Kim NH, Oh JH, Seo JA, Lee KW, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR 2005 Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int 67:167-177
13. 2000 Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183:1-22